Mevis Medical Solutions Ag Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2018; Revises Earnings Guidance for Fiscal 2018
Revenues thus amounted to EUR 12,133,000 in the first nine months of the year, against EUR 14,196,000 for the same period a year ago, which EUR 8,192,000 was attributable to the Digital Mammography segment against previous year's EUR 8,984,000 and EUR 3,941,000 to Other Diagnostics against previous year's EUR 5,212,000. EBIT (earnings before financial result and taxes) of EUR 4,440,000 in the first nine months of fiscal 2018, compared to EUR 5,327,000 in the previous year's period.
For the year 2018 a significant decrease in revenues to EUR 16.0 million to EUR 16.5 million is now expected (previous forecast for fiscal year 2018: significant decrease to EUR 14.5 million to EUR 15.0 million). For fiscal year 2018 a significant decrease in the EBIT (earnings before interest and taxes) is expected to EUR 5.5 million to EUR 6.0 million (previous forecast for fiscal year 2018: decrease in EBIT to EUR 3.0 million to EUR 3.5 million).